Involvement of reactive oxygen species in TNF-α mediated activation of the transcription factor NF-κB in canine dermal fibroblasts

Veterinary Immunology and Immunopathology

Volumn 71, Issue 2, 1999, Pages 125-142

  Kohler H B K ^a   Knop, J ^b   Martin, M ^b   De Bruin, A ^c   Huchzermeyer, B ^a   Lehmann, H ^a   Kietzmann, M ^d   Meier, B ^e   Nolte, I ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d Inst Pharmakol Toxikol/Pharm   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Canine fibroblasts; Nuclear factor B; Redox regulation; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOG; ELECTRON ENERGY LOSS SPECTROSCOPY; ELECTROPHORETIC MOBILITY; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION REACTION; SKIN FIBROBLAST;

ANIMALS; CERIUM; CYTOCHROME C GROUP; DINOPROSTONE; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; HYDROGEN PEROXIDE; MICROSCOPY, ELECTRON; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SKIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

ANGUILLIFORMES; CANIS FAMILIARIS;

EID: 0032861205     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(99)00097-5     Document Type: Article

References (49)

1. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
2. Baldwin A.S. The NF-κB and I-κB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-681.
3. Bauer R. Electron spectroscopic imaging: an advanced technique for imaging and analysis in transmission electron microscopy. Methods Microbiol. 20:1988;113-146.
4. Bierhaus A., Chevion S., Hofmann M., Quehenberger P., Illmer T., Luther T., Beerenstein E., Tritschler H., Müller M., Wahl P., Ziegler R., Nawroth P.P. Advanced glycation end product-induced activation of NF-κB is suppressed by α-Lipoic acid in cultured endothelial cells. Diabetes. 46:1997;1481-1490.
5. Bradford M.M. A rapid and sensitive method for the quantification of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Brennan P., O'Neill L. Effects of oxidants and antioxidants on NF-κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta. 1260:1995;167-175.
7. Brigelius-Flohé R., Bilgin B., Eickemeier S., Hipskind R., Singh M., Szamel M., Resch K. The NF-κB heterodimer/homodimer balance and IL-1-stimulated IL-2 production in murine T lymphocytes. Biofactors. 9:1996;1-6.
8. Briggs R.T., Draht D.B., Karnovsky M.L., Karnovsky M.J. Localization of NADH oxidase on the surface of human polymorphonuclear leukocytes by a new cytochemical method. J. Cell Biol. 67:1975;566-586.
9. Chance B., Sies H., Boveris A. Hydrogen peroxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605.
10. 2 by brain mitochondria: the effect of reoxygenation following postdecapitative ischemia. Arch. Biochem. Biophys. 269:1989;623-638.
11. 2 sensor protein in the rat carotid body. Biochem. J. 272:1990;743-747.
12. Darnay B.G., Aggarwal B.B. Early events in TNF-signaling: a story of associations and dissociations. J. Leukocyte Biol. 61:1997;559-566.
13. Dignam J.D., Lebovitz R.M., Roederer R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
14. Dinarello C.A. Role of pro-and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J. Biol. Regul. Homeost. Agents. 11:1997;91-103.
15. Fiers W. Tumor necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Lett. 285:1991;199-212.
16. Flohé L., Brigelius-Flohé R., Saliou C., Traber M., Packer L. Redox regulation of NF-Kappa B activation. Free Rad. Biol. Med. 20:1997;1115-1126.
17. Handelman G.J., Han D., Tritschler H., Packer L. Alpha-lipoic acid reduction by mammalian cells to the dithiol form and release into the culture medium. Biochem. Pharmacol. 47:1994;1725-1730.
18. 2 is crucial in the cytotoxic action of TNF. J. Biol. Chem. 268:1993;11290-11295.
19. Hayashi T., Ueno Y., Okamoto T. Oxidoreductive regulation of nuclear factor-(B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268:1993;11380-11388.
20. Higuchi M., Singh S., Chan H., Aggarwal B.B. Protease inhibitors differentially regulate TNF-induced apoptosis, NF-κB activation, cytotoxicity and differentiation. Blood. 86:1995;2248-2256.
21. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-Kappa B activation. Cell. 81:1995;495-498.
22. Israel N., Gourgerot-Pocidalo M.A., Aillet F., Virelizier J.L. Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149:1992;3386-3393.
23. Iwasaki T., Sims J., Grabstein K., Dower S.K., Rachie N., Bomsztyk K. Comparison of II-1α effectiveness in activating murine pre-B and T cell lines. Cytokine. 5:1993;416-426.
24. Kausch A.P., Wagner B.L., Horner H.T. Use of cerium chloride technique and energy dispersive X-ray microanalysis in plant peroxisome identification. Protoplasma. 118:1983;1-9.
25. Kretz-Remy C., Mehlen P., Mirault M.-E., Arrigo A.-P. Inhibition of I-κB-α phosphorylation and degradation and subsequent NF-κB activation by glutathione peroxidase overexpression. J. Cell. Biol. 133:1996;1083-1093.
26. Kupper T.S. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J. Invest. Dermatol. 94:1990;146S-150S.
27. Lehmann H., Kunz U., Jacob A. A simplified preparation procedure of plant material for elemental analysis by ESI and EELS techniques. J. Microscopy. 162:1991;77-82.
28. Leung D.Y.M. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol. 96:1995;302-318.
29. Los M., Dröge W., Stricker K., Baeuerle P.A., Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T-lymphocyte functions. Eur. J. Immunol. 25:1995;159-165.
30. McCord J.M., Fridovich I. The reduction of cytochrome c by milk xanthine oxidase. J. Biol. Chem. 243:1969;5753-5760.
31. Meier B., Cross A.R., Hancock J.T., Kaup F.J., Jones O.T.G. Identification of a superoxide generating NADPH-oxidase system in human fibroblasts. Biochem. J. 275:1991;241-245.
32. Meier B., Radeke H.H., Selle S., Sies H., Resch K., Habermehl G.G. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor α Biochem. J. 263:1989;539-545.
33. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: Ap-1 as secondary antioxidant-responsive factor. EMBO J. 12:1993;2005-2015.
34. O'Donnell V., Spycher S., Azzi A. Involvement of oxidants and oxidant-generating enzymes in TNF-α-mediated apoptosis: a role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem. J. 310:1995;133-141.
35. Packer L., Witt E., Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Rad. Biol. Med. 19:1995;227-250.
36. Schliephake H., Lehmann H., Kunz U., Schmelzeisen R. Ultrastructural findings in soft tissues adjacent to titanium plates used in jaw fracture treatment. Oral Maxillofac. Surg. 22:1993;20-25.
37. Schmidt K.N., Amstad P., Cerutti P., Baeuerle P.A. The roles of hydrogen peroxide and superoxide as messengers in the activation of the transcription factor NF-κB. Chem. Biol. 2:1995;13-22.
38. Schreck R., Bauerle P.A. A role for oxygen radicals as second messengers. Trends Cell Biol. 1:1991;39-42.
39. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
40. Schütze S., Potthoff K., Machleidt T., Berkovik D., Wiegmann K., Krönke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase c-induced acidic sphingomyelin breakdown. Cell. 71:1992;765-776.
41. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12:1993;3095-3104.
42. Sen C.K., Packer L. Antioxidant and redoxregulation of gene transcription. FASEB J. 5:1996;709-720.
43. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobin enhancer sequences. Cell. 46:1986;705-716.
44. Suzuki Y.J., Aggarwal B.B., Packer L. Alpha-lipoic acid is a potent inhibitor of NF-κB activation in human T-cells. Biochem. Biophys. Res. Commun. 189:1992;1709-1715.
45. Thanos D., Maniatis T. NF-κB: a lesson in family values. Cell. 80:1995;529-532.
46. Traenckner B.M., Wilk W., Baeuerle P.A. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:1994;5433-5441.
47. Wilkinson J.E., Smith C., Suter M., Lewis R.M. Long-term cultivation of canine keratinocytes. J. Invest. Dermatol. 88:1987;202-206.
48. Wu R.-L., Chen T., Sun T.-T. Functional importance of an Sp1-and an NF-κB-related nuclear protein in a keratinocyte-specific promoter of rabbit K3 keratin gen. J. Biol. Chem. 269:1994;28450-28459.
49. Zucker K., Lu P., Fuller L., Asthana D., Esquenazi V., Miller J. Cloning and expression of the c-DNA for canine tumor necrosis factor-alpha in E. coli. Lymphokine-Cytokine-Res. 13:1994;191-196.